| PERIOD ENDING | 29-Mar-09 | 31-Dec-08 | 28-Sep-08 | 29-Jun-08 | | Total Revenue | 10,867,000 | 12,346,000 | 11,973,000 | 12,129,000 | | Cost of Revenue | 1,408,000 | 1,715,000 | 2,122,000 | 2,289,000 | | | Gross Profit | 9,459,000 | 10,631,000 | 9,851,000 | 9,840,000 | | | Operating Expenses | | Research Development | 1,705,000 | 2,303,000 | 1,885,000 | 1,966,000 | | Selling General and Administrative | 2,819,000 | 3,659,000 | 3,523,000 | 3,863,000 | | Non Recurring | 554,000 | 1,407,000 | 600,000 | 725,000 | | Others | 578,000 | 605,000 | 621,000 | 663,000 | | | | Total Operating Expenses | 5,656,000 | 7,974,000 | 6,629,000 | 7,217,000 | | | | Operating Income or Loss | 3,803,000 | 2,657,000 | 3,222,000 | 2,623,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (1,516,000) | (500,000) | 167,000 | | Earnings Before Interest And Taxes | 3,803,000 | 1,141,000 | 2,722,000 | 2,790,000 | | Interest Expense |
-
| 516,000 |
-
|
-
| | Income Before Tax | 3,803,000 | 625,000 | 2,722,000 | 2,790,000 | | Income Tax Expense | 1,074,000 | 394,000 | 463,000 | 25,000 | | Minority Interest |
-
| (5,000) | (6,000) | (6,000) | | | | Net Income From Continuing Ops | 2,729,000 | 226,000 | 2,253,000 | 2,759,000 | | | Non-recurring Events | | Discontinued Operations | 1,000 | 40,000 | 25,000 | 17,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,730,000 | 266,000 | 2,278,000 | 2,776,000 | | Preferred Stock And Other Adjustments | (1,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,729,000 | $266,000 | $2,278,000 | $2,776,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
